Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2021-12-13 Director's Dealing
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
110年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document is lengthy and contains actual data, not just an announcement or certification. Therefore, it fits best under the category of Director's Dealing (DIRS).
2021-12-13 Chinese
110年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It focuses on the personal share transactions and holdings of insiders rather than financial results, management changes, or meeting materials. The presence of insider names, titles, and shareholding details strongly indicates this is a report on insider share transactions or holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is about 4617 characters, which is sufficient for a detailed insider shareholding report. There is no indication of financial statements, earnings, or meeting results, so other categories like 10-K, ER, or DVA are not applicable.
2021-12-13 Chinese
110年12月法人說明會簡報 — 474620211208E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation by Formosa Laboratories Inc. It includes company profile, business updates, product lines, operational results, and market share information. The content is structured with slides, charts, and forward-looking statements. There is no indication that this is an official annual or quarterly report, audit report, or regulatory filing. It is not a transcript of a call or a voting result announcement. The document is a comprehensive overview aimed at investors or stakeholders, focusing on financials, strategy, and market position. This matches the definition of an Investor Presentation (IP). The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2021-12-08 Chinese
110年12月法人說明會簡報 — 474620211208M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation about the company's business operations, product lines, manufacturing capabilities, and market outlook. It includes financial performance data up to November 2021, product revenue breakdowns, and descriptions of research and development activities. The content is structured with slides and images (omitted here) and includes forward-looking statements and disclaimers typical of investor presentations. There is no indication that this is a formal annual or quarterly report, audit report, or regulatory filing. It is not a transcript of a call or a voting result announcement. The document length (8007 characters) and the nature of the content (business overview, financial highlights, operational details) strongly suggest it is an Investor Presentation (IP).
2021-12-08 Chinese
110年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, summary, and links to presentation files. The content is focused on a scheduled or held investor presentation event rather than a full report or financial statements. The document length is short (744 characters) and it provides links to presentation materials rather than containing the materials themselves. This matches the definition of an Investor Presentation (IP) filing, which is a detailed presentation for investors focusing on financials, strategy, and market position.
2021-12-08 Chinese
本公司受邀參加第一金證券線上投資座談會
Regulatory Filings Classification · 90% confidence The document is a short announcement (631 characters) about the company (4746 台耀) participating in an online investor conference hosted by First Securities. It includes details such as date, time, location, and a brief summary of the event, which is a presentation of company performance and outlook. There are no financial statements or detailed financial data included. The document serves as a notification of an investor presentation event rather than the presentation itself or a detailed report. According to the rules, such announcements about investor presentations are classified as Investor Presentation (IP) if they contain the presentation itself, but here it only announces participation and provides a summary, so it is more aligned with Regulatory Filings (RNS) as a general regulatory announcement. The document is not a full transcript or detailed presentation, nor is it a report publication announcement. Therefore, the best fit is Regulatory Filings (RNS).
2021-12-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.